Kinetics of HIV-1 CTL Epitopes Recognized by HLA I Alleles in HIV-Infected Individuals at Times near Primary Infection: The Provir/Latitude45 Study

• Jennifer Papuchon,

  Affiliation University Hospital of Bordeaux and CNRS UMR 5234, Bordeaux, France

  ⨯
• Patricia Pinson,

  Affiliation University Hospital of Bordeaux and CNRS UMR 5234, Bordeaux, France

  ⨯
• Gwenda-Line Guidicelli,

  Affiliation University Hospital of Bordeaux and CNRS UMR 5164, Bordeaux, France

  ⨯
• Pantxika Bellecave,

  Affiliation University Hospital of Bordeaux and CNRS UMR 5234, Bordeaux, France

  ⨯
• Réjean Thomas,

  Affiliation Clinique médicale l'Actuel, Montréal, Canada

  ⨯
• Roger LeBlanc,

  Affiliation Clinique médicale Opus, Montréal, Canada

  ⨯
• Sandrine Reigadas,

  Affiliation University Hospital of Bordeaux and CNRS UMR 5234, Bordeaux, France

  ⨯
• Jean-Luc Taupin,

  Affiliation University Hospital of Bordeaux and CNRS UMR 5164, Bordeaux, France

  ⨯
• Jean Guy Baril,

  Affiliation Clinique Médicale du Quartier Latin, Montréal, Canada

  ⨯
• Jean Pierre Routy,

  Affiliation McGill University Health Centre, Montréal, Canada

  ⨯
• Mark Wainberg,

  Affiliation McGill AIDS Centre, Montréal, Canada

  ⨯
• Hervé Fleury ,

  * E-mail: herve.fleury@viro.u-bordeaux2.fr

  Affiliation University Hospital of Bordeaux and CNRS UMR 5234, Bordeaux, France

  ⨯
• the Provir/Latitude 45 study group

  ¶Membership of the Provir/Latitude 45 study group is provided in the Acknowledgments.

  ⨯